Your search returned 3 results.

Results
	1.	Ganciclovir pharmacokinetic parameters do not change when extending valganciclovir cytomegalovirus prophylaxis from 100 to 200 days. [electronic resource] by Welker, Horst Farhan, Mahdi Humar, Atul Washington, Carla Producer: 20110128 In: Transplantation vol. 90 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Evaluation of the effect of multiple-dose administration of R411, a dual alpha4beta1-alpha4beta7 integrin antagonist on the major CYP isoform activities in healthy volunteers. [electronic resource] by Hijazi, Youssef Welker, Horst Dorr, Albert E Frank, Karl Renzetti, Louis M Patel, Indravadan Producer: 20070116 In: European journal of clinical pharmacology vol. 62 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Pharmacokinetics, safety, and tolerability of R411, a dual alpha4beta1-alpha4beta7 integrin antagonist after oral administration at single and multiple once-daily ascending doses in healthy volunteers. [electronic resource] by Hijazi, Youssef Welker, Horst Dorr, Albert E Tang, Jian-Ping Blain, Roger Renzetti, Louis M Abbas, Richat Producer: 20050408 In: Journal of clinical pharmacology vol. 44 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search